Tag: newswire

BROOKFIELD, NEWS, June 30, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners will hold its second quarter 2025 conference call and webcast on Thursday, July 31, 2025 at 9:00 a.m. (ET).

KINGSTOWN, Saint Vincent and the Grenadines, June 30, 2025 (GLOBE NEWSWIRE) -- Amid a growing wave of phishing scams targeting the crypto industry, Millionero, a trusted spot and perpetual exchange, is taking a stand. The company is urging all users to stay vigilant and follow key safety measures as scammers impersonate brands, executives, and platforms with increasing sophistication.

BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight® Dx*—its digital pathology image management system—for use in primary diagnosis in clinical settings. Building on the initial 510(k) clearance for AISight Dx(Novo) in 2022, this latest milestone underscores the platform’s continuous innovation and PathAI’s commitment to delivering enhanced capabilities as the product evolves.

SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), have until August 25, 2025 to seek appointment as lead plaintiff of the Sarepta class action lawsuit. Captioned Dolgicer v. Sarepta Therapeutics, Inc., No. 25-cv-05317 (S.D.N.Y.), the Sarepta class action lawsuit charges Sarepta and certain of Sarepta’s top executives with violations of the Securities Exchange Act of 1934.

SHANGHAI, China, June 30, 2025 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today announced that the following proposed resolutions submitted for shareholder approval have been duly adopted at its annual general meeting of shareholders held today:

— Approval based on Phase III SACHI Trial results which showed a 66% reduced risk of progression or death as compared to platinum-based chemotherapy —

THE HAGUE, The Netherlands, June 30, 2025 (GLOBE NEWSWIRE) -- In a strategic move to improve patient outcomes in breast cancer, Affidea, a leading pan-European provider of community-based polyclinics, specialist services and advanced diagnostics, is proud to announce that it has selected b-rayZ, a leader in AI-powered breast imaging solutions, as its preferred AI partner for breast imaging.

First-ever Westin beachfront condo-hotel in Panama combines residential living with hospitality-backed rental potential

서울, 대한민국, June 30, 2025 (GLOBE NEWSWIRE) -- 글로벌 암호화폐 거래소 BYDFi가 6월 26일부터 27일까지 서울 COEX 컨벤션 센터 3층 오디토리움에서 개최되는 Seoul Meta Week 2025: METACON (SMW2025) 에 참가합니다.